from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2304c/-

LFCtreatmentdescriptionclass of inhibitor

0.826

Amikacinug/mL Amikacintranslation

1.669

Cap5-10ug/mL Capreomycintranslation

2.033

Rox10-50 ug/mL Roxithromycintranslation

0.057

SM2-5 ug/mL Streptomycintranslation

1.527

Tet5-10 ug/mL Tetracyclinetranslation

-1.295

Rif0.2-5ug/mL Rifampicintranscription

-0.841

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.328

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.435

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.113

CPZ10-50 ug/mL Chlorpromazinerespiration

0.942

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.170

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.959

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.597

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.418

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.145

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.121

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.031

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.427

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.227

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.980

KCN5-20 ug/mL Potassium cyaniderespiration

0.985

NaN30.2-2 mM Sodium aziderespiration

0.880

Nigericin50 uM Nigericinrespiration

-0.272

TRC10-150 ug/mL Triclosanrespiration

1.762

TRZ10-25 ug/mL Thioridazinerespiration

2.006

Valinomycin0.5-10 uM Valinomycinrespiration

0.270

ZnSO42 mM ZnSO4respiration

0.315

menadione6-10 ug/mL Menadionerespiration

-0.010

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.184

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.371

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.017

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.058

NRP_1Non-replicating persistence stage 1dosRassociated

-0.547

Amp0.2mg/mL AmpicillincellWall

-0.257

Cephalexin20-100 ug/mL CephalexincellWall

0.030

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.112

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.689

EMB10-20 ug/mL EthambutolcellWall

-0.150

Eta12-40 ug/mL EthionamidecellWall

-0.221

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.509

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.854

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.447

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.199

BZA0.12 mg/mL BenzamidearomaticAmides

-0.144

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.175

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.907

H2O24 mM hydrogen peroxideDNAdamaging

-0.415

Levo10 ug/mL LevofloxacinDNAdamaging

-0.975

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.756

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.648

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.755

UVUV-irradiationDNAdamaging

1.642

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.387

Antimycin12.5-50 ug/mL Antimycin A?

0.165

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.250

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.336

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.621

PA8240.2-2 ug/mL PA-824?

1.188

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.087

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.349

Verapamil50 uM Verapamil?

0.229

mercaptoethanol2 mM 2-Mercaptoethanol?

0.230

methoxatin10-20 ug/mL Methoxatin?